Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

HK Stock Market Move | ADICON HOLDINGS (09860) rose more than 8% in early trading, with AI giants competing to seize the AI medical market. Domestic AI medical applications have taken the lead in practice.

HK Stock Market Move | AI applications are soaring across the board. MARKETINGFORCE (02556) leads the way with a gain of over 15%, expanding its lead in the sector.

Kangqiao Ser (02205) appoints Zhang Yanfei as the responsible person for investor relations to help deepen the globalization strategy.
HK Stock Market Move | ADICON HOLDINGS (09860) rose more than 8% in early trading, with AI giants competing to seize the AI medical market. Domestic AI medical applications have taken the lead in practice.

HK Stock Market Move | AI applications are soaring across the board. MARKETINGFORCE (02556) leads the way with a gain of over 15%, expanding its lead in the sector.

Kangqiao Ser (02205) appoints Zhang Yanfei as the responsible person for investor relations to help deepen the globalization strategy.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


